 |
31 Diseases |  |
34 Trials |
|
34 Trials |  |
1690 News |  |
| «12...78910111213141516171819 |
- ||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion, Combination therapy: Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone (clinicaltrials.gov) - Apr 3, 2012
P3, N=278, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed
- || Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly, Jentadueto (linagliptin/metformin) / Eli Lilly, Boehringer Ingelheim
Enrollment change: Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet (clinicaltrials.gov) - Mar 6, 2012
P1, N=58, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed N=18 --> 58
- Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
New P4 trial: Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus (clinicaltrials.gov) - Feb 20, 2012
P4, N=40, Recruiting, Sponsor: Marcus Borchert
- ||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly, Jentadueto (linagliptin/metformin) / Eli Lilly, Boehringer Ingelheim
New P4 trial, Monotherapy, Head-to-Head: Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes (clinicaltrials.gov) - Jan 18, 2012
P4, N=316, Completed, Sponsor: Boehringer Ingelheim Pharmaceuticals
- ||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion: Comprehensive Add on Study in Japan (clinicaltrials.gov) - Jan 16, 2012
P3, N=574, Completed, Sponsor: Boehringer Ingelheim
N=18 --> 58 Active, not recruiting --> Completed
- ||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly, Jentadueto (linagliptin/metformin) / Eli Lilly, Boehringer Ingelheim
Trial completion: Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet (clinicaltrials.gov) - Jan 11, 2012
P1, N=58, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion: Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study (clinicaltrials.gov) - Oct 18, 2011
P3, N=234, Completed, Sponsor: Boehringer Ingelheim
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
Trial completion, Combination therapy: Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes (clinicaltrials.gov) - Sep 21, 2011
P3, N=1263, Completed, Sponsor: Boehringer Ingelheim
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Tradjenta (linagliptin) / Boehringer Ingelheim, Eli Lilly
New P4 trial, Combination therapy: Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control (clinicaltrials.gov) - Sep 20, 2011
P4, N=689, Completed, Sponsor: Boehringer Ingelheim Pharmaceuticals